Well, I'm happy to answer again. Just quickly, we in the generic pharmaceutical industry have worked throughout this very closely with distributors and pharmacies in Canada, and with our own member companies. Our own member companies are, as was said, required to report all shortages wherever there has been a shortage.
There was a concern at one time about the increased use of sedatives and muscle relaxants, etc., in intensive care units treating COVID patients. Our companies were able to repurpose to increase production and increase the products coming into Canada. We worked with Health Canada. We worked with the group purchasing organizations in the provinces. We ensured that products were available in all cases throughout the pandemic.
As we said earlier in our presentation, we are quite proud of the fact that a lack of medicines, or shortages of medicines, never became a major problem for Canada, even at the worst of the pandemic shock that we faced.